The obesity therapeutics industry grows at 20.6% CAGR to US$20.84 billion by 2033, propelled by US$5.3 billion deals and oral GLP-1 advancements. Learn about global shifts toward sustainable, accessible treatments for rising obesity prevalence. https://finance.yahoo.com/news/competitive-landscape-obesity-therapeutics-market-141800112.html